Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Recruiting2
Active Not Recruiting1

Clinical Trials (3)

Showing 3 of 3 trials
NCT07497724Active Not RecruitingPrimary

Odevixibat Outcomes in Patients With PFIC Versus an External Control Cohort (OvEC-PFIC)

NCT07411716RecruitingPrimary

Pediatric Evaluation and Registry for Liver Cholestasis in Canada

NCT07191704RecruitingPrimary

A Study to Assess the Genetic Variations in Bile Flow Disorders: Linking Progressive Familial Intrahepatic Cholestasis (PFIC)-Related Genes to Symptoms in Adults With Recurrent Cholestasis in Spain

Showing all 3 trials

Research Network

Activity Timeline